Trial Profile
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2020
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms AEIOU
- 09 May 2017 Status changed from recruiting to completed.
- 18 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 18 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017.